CXADR and breast cancer: Our finding suggests that alternative Ad types Ad3, Ad35, Ad37, and Ad52 transduce BC in a CAR-independent manner; these Ad types should be further engineered to oncolytic virus enabling tumor-specific replication and improved immunogenic response to the tumor environment.